CURR OPIN BIOTECH 润色咨询

CURRENT OPINION IN BIOTECHNOLOGY

出版年份:1990 年文章数:2450 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:1.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=4f53720, cover=https://img.medsci.cn/images/journal/cover/2021/Mxu_202109271314491700.jpg, fullname=CURRENT OPINION IN BIOTECHNOLOGY, abbr=CURR OPIN BIOTECH, pyear=1990, frequence=Bimonthly, articleNumbers=2450, citedSelf2015=1.9, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0958-1669, greenSci=https://www.greensci.net/search?kw=0958-1669, scijournal=https://www.scijournal.org/impact-factor-of-CURR-OPIN-BIOTECH.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.806, medsciHotlight=2.283, medsciHotlight5year=4.48374, citescore=15.7, hIndex=202, impactFactor=7.7, orgnization=Elsevier Ltd., orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=1, isOaString=是, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=工程技术 1区[Top], smallclassCas=工程技术 1 区, website=https://www.sciencedirect.com/journal/current-opinion-in-biotechnology, websiteHits=6623, guideForAuthor=https://www.elsevier.com/journals/current-opinion-in-biotechnology/0958-1669/guide-for-authors, guideForAuthorHits=187, submitWebsite=https://www.evise.com/evise/faces/pages/login/login.jspx?resourceUrl=%2, submitWebsiteHits=1205, content=<p><em style="color: #2e2e2e;"><strong>Current Opinion in Biotechnology (COBIOT)</strong></em><span style="color: #2e2e2e;"> publishes authoritative, comprehensive, and systematic reviews. </span><em style="color: #2e2e2e;">COBIOT</em><span style="color: #2e2e2e;"> helps specialists keep up to date with a clear and readable synthesis on current advances biotechnology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><em style="color: #2e2e2e;"><strong>Current Opinion in Biotechnology</strong></em><span style="color: #2e2e2e;"> is part of the </span><u style="color: #2e2e2e;"><a href="https://www.elsevier.com/life-sciences/journals/core">Current Opinion and Research (CO+RE) suite of journals</a></u><span style="color: #2e2e2e;"> and is a companion to the new primary research, open access journal, </span><a href="https://www.journals.elsevier.com/current-research-in-biotechnology">Current Research in Biotechnology (CRBIOT)</a><span style="color: #2e2e2e;">. CO+RE journals leverage the </span><em style="color: #2e2e2e;">Current Opinion</em><span style="color: #2e2e2e;"> legacy of editorial excellence, high-impact, and global reach to ensure they are a widely read resource that is integral to scientists workflow.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><em style="color: #2e2e2e;"><strong>Current Opinion in Biotechnology</strong></em><span style="color: #2e2e2e;"> is divided into themed sections, each of which is reviewed once a year. Themes include analytical biotechnology; plant biotechnology; food biotechnology; energy biotechnology; environmental biotechnology; systems biology; nanobiotechnology; tissue, cell and pathway engineering; chemical biotechnology; and pharmaceutical biotechnology.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">The journal builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.</span></p> <ul style="color: #2e2e2e;"> <li><strong>Expertise</strong> Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.</li> <li><strong>Comprehensiveness</strong> There are 27 high-impact <em>Current Opinion</em> review journals in a range of subjects from food science to green and sustainable chemistry.</li> <li><strong>Impact</strong> In addition to a vast readership, <em>Current Opinion</em> titles enjoy high citations, Impact Factors, and CiteScores.</li> </ul>, totalCites=18869, brief=CURR OPIN BIOTECH杂志工程技术行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=生物工程与应用微生物" >生物工程与应用微生物</a></strong>”子行业的顶级杂志, articleType=本刊可能只接收综述类文章或很多文章不被WOS收录, medsciHeat=黑红, medsciComment=CURR OPIN BIOTECH在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=4f53720'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=8.55), GetImpactFactorCiteScoreListResponse(year=2017, citescore=8.45), GetImpactFactorCiteScoreListResponse(year=2018, citescore=8.45), GetImpactFactorCiteScoreListResponse(year=2019, citescore=15.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=15.7)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.501), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.296), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.918), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.903), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.806)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Engineering - Biomedical Engineering , rank=8/205), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Biotechnology , rank=11/257), GetImpactFactorCiteScoreGradeResponse(smallClass=Chemical Engineering - Bioengineering , rank=11/139)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=BIOCHEMICAL RESEARCH METHODS, rank=Q1), GetImpactFactorCiteScoreGradeResponse(smallClass=BIOTECHNOLOGY & APPLIED MICROBIOLOGY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0958-1669[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CURRENT OPINION IN BIOTECHNOLOGY[ta], article_number=225, article_number_cn=18, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CURR OPIN BIOTECH/CURRENT OPINION IN BIOTECHNOLOGY
ISSN
0958-1669
影响指数话题
预警等级
MedSci期刊指数
1.806 (MedSci实时期刊指数) | 4.48374 (5年期刊指数)
CiteScore值
15.7
h-index
202
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier Ltd. 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Bimonthly
出版年份
1990
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
BIOCHEMICAL RESEARCH METHODS Q1
BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q1
中科院分区
大类:工程技术 1区[Top]
小类:工程技术 1 区